Company: IPSC
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001104659-25-037419
Chunk: 33

Company: Century Therapeutics, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 33
---
836,627 |              ​ | ​ | 166,724 |                  ​ | ​ | 13,200 |                                         ​ | ​ | 1,709,916 |                           ​ | ​ |   |           |   |   |

(1) Amounts shown in this column do not reflect dollar amounts actually received by our NEOs. Instead, these amounts reflect the aggregate grant date fair value of each stock option, determined in accordance with the provisions of FASB ASC Topic 718. The assumptions made in the calculation of these amounts are included in Note 2 of the Notes to the Consolidated Financial Statements included in our 2024 Annual Report. (2) Amounts shown for 2024 are cash incentive payments earned in respect of 2024 performance and paid in the first quarter of 2025. Amounts shown for 2023 are cash incentive payments earned in respect of 2023 performance and paid in the first quarter of 2024. (3) Unless otherwise noted, amounts represent 401(k) matching contributions. (4) Dr. Pfeiffenberger was appointed President and Chief Executive Officer in December 2023. (5) Represents a retention bonus paid in 2024 to Dr. Pfeiffenberger in connection with the commencement of his employment with us, subject to repayment in full if Dr. Pfeiffenberger’s employment terminates for any reason other than death, disability, resignation for good reason, or termination without cause, in each case prior to the one-year anniversary of his start date. (6) Represents (i) 401(k) matching contributions in an amount of $13,800 and (ii) reimbursement for relocation expenses Dr. Pfeiffenberger received in an amount of $258,929. (7) Represents a signing bonus Dr. Pfeiffenberger received in connection with the commencement of his employment with us. Narrative to the Summary Compensation Table and Elements of Compensation The compensation of our NEOs generally consists of base salary, annual cash incentive opportunities, long-term incentive compensation in the form of equity awards, and other benefits, as described below. Base salary The base salary payable to each NEO is intended to provide a fixed component of compensation reflecting the executive’s skill set, experience, role, responsibilities, and contributions. Each NEO’s initial base salary was specified in his or her employment agreement, as described below, and is reviewed (and, if applicable, adjusted) from time to time by our Board or Compensation Committee, as applicable.